Tag: Pneumonia
Recommendations Simplified for Pneumococcal Vaccination
ACIP recommends PCV20 alone or PCV15 in series with PPSV23 for all aged 65 years and older or younger adults at risk
New Model Predicts Pediatric Pneumonia With Reduced X-Ray Need
Three variables in the model included age, fever duration, and decreased breath sounds
Regular Physical Activity Can Help Cut Pneumonia Risk
The most physically active groups in the general population had lower risk for incident pneumonia and pneumonia-related mortality
Air Pollution Exposure Linked to Pneumonia in Children
Exposure to PM2.5 above 10.75 µg/m3 associated with residence in area with high risk for community-acquired pneumonia in children
Risk for Asthma at Age 4 Years Higher After Pneumonia in Infancy
Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine
Postop Pneumonia Risk Up With Pediatric Neurologic Comorbidity
Almost twofold higher risk seen with presence of preoperative neurologic comorbidity; length of stay also up with neurologic comorbidity
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
Some Inflammatory Diseases Linked to Stroke-Associated Pneumonia
Risk for SAP reduced among patients with psoriasis, other chronic inflammatory diseases among acute ischemic stroke discharges
Crohn Disease, Comorbidities Up Risk for Severe Pneumococcal Disease
Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination
